EpiPen litigation comes back to haunt Teva a decade after initial settlements — Pfizer's search for Paxlovid's COVID-busting sibling leads to low-profile antiviral biotech —Mirati to focus adagrasib/Keytruda study in low PDL1 lung cancer patients -- See more on our front page news http://bit.ly/w28kSd #epipen #tevapharm #legal #pfizer #covid #covid19 #paxlovid #antivirals #lungcancer #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
#epipen #tevapharm #legal #pfizer #covid #covid19 #Paxlovid #Antivirals #lungcancer #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
Merck buying out blood cancer biotech Imago for $1.4B — Teva taps former Sandoz head Francis as next CEO —AbbVie's blood cancer bispecific gets FDA priority review -- See more on our front page news http://bit.ly/w28kSd #merck #bloodcancer #mergersandacquisitions #ceos #tevapharm #abbvie #bispecificantibodies #fda #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#merck #bloodcancer #mergersandacquisitions #ceos #tevapharm #abbvie #bispecificantibodies #FdA #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma